Feasibility of the LUM Imaging System for Detection of Prostate Cancer

NCT03441464 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Interim analysis indicated a change in study design to collect in vivo data

Conditions

Prostate Cancer
Neoplasm, Residual

Interventions

COMBINATION_PRODUCT: LUM Imaging System

Sponsor

Lumicell, Inc.